| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.11B | -2.7% |
| R&D Expense | $1.32B | -43.1% |
| SG&A Expense | $1.04B | -34.9% |
| Operating Income | -$161.7M | +94.0% |
| Interest Expense | $82.8M | -6.9% |
| Pre-tax Income | -$76.8M | +97.5% |
| Income Tax | -$171.7M | +60.9% |
| Net Income | $94.9M | +103.6% |
| EPS (Basic) | $0.40 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.14B | +16.1% |
| Accounts Receivable | $168.3M | -23.6% |
| Current Assets | $203.47B | +135.4% |
| Total Assets | $206.98B | +130.7% |
| Current Liabilities | $197.71B | +144.6% |
| Long-term Debt | $2.98B | -12.2% |
| Total Liabilities | $200.70B | +138.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $923.0M | +158.2% |
| Investing Cash Flow | $5.4M | +100.8% |
| Financing Cash Flow | -$811.3M | +86.1% |
| +103.4% |
| EPS (Diluted) | $0.37 | +103.1% |
| Stockholders' Equity |
| $6.28B |
| +15.2% |